nebulizer (capnopen (Capnomed GmbH)
90
Structured Review
Capnomed GmbH
nebulizer (capnopen
Nebulizer (Capnopen, supplied by Capnomed GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nebulizer+(capnopen/nebulizer+capnopen/nct03280511-20-11-13
Average 90 stars, based on 1 article reviews
Nebulizer (Capnopen, supplied by Capnomed GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nebulizer+(capnopen/nebulizer+capnopen/nct03280511-20-11-13
Average 90 stars, based on 1 article reviews
nebulizer (capnopen - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Injection:Article Title: First-line palliative systemic therapy alternated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: A single-arm phase II trial (CRC-PIPAC-II). Article Snippet: Background: Palliative systemic therapy alternated with electrostatic precipitation oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (ePIPAC) has never been prospectively investigated in patients with unresectable colorectal peritoneal metastases (CPM).. The CRC-PIPAC-II study aimed to assess safety, feasibility and efficacy of such bidirectional therapy.. Methods: This two-center, single-arm, phase II trial enrolled chemotherapy-naïve patients to undergo three treatment cycles, consisting of systemic therapy (CAPOX, FOLFOX, FOLFIRI, or FOLFOXIRI, all with bevacizumab) and oxaliplatin-based ePIPAC (92 mg/m2) with intravenous leucovorin (20 mg/m2) and 5-fluorouracil (400 mg/m2). Article Title: Enhanced intraperitoneal delivery of charged, aerosolized curcumin nanoparticles by electrostatic precipitation. Article Snippet: Therapeutic solutions were aerosolized at Article Title: Comparing patient reported abdominal pain between patients treated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC-OX) and primary colorectal cancer surgery. Article Snippet: Oxaliplatin was prepared in a total volume of 150 mL Article Title: Standardizing training for Pressurized Intraperitoneal Aerosol Chemotherapy. Article Snippet: Furthermore, important practical and safety aspects have been summarized comprehensively(1, 6- 8) Of note, access to the Article Title: Nab-PIPAC: a phase IB study protocol of intraperitoneal cisplatin and nab-paclitaxel administered by pressurised intraperitoneal aerosol chemotherapy (PIPAC) in the treatment of advanced malignancies confined to the peritoneal cavity Article Snippet: Cisplatin 10.5 mg/m2 body surface in 150 ml Article Title: Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Oxaliplatin, Cisplatin, and Doxorubicin in Patients with Peritoneal Carcinomatosis: An Open-Label, Single-Arm, Phase II Clinical Trial Article Snippet: A Aerosol:Article Title: First-line palliative systemic therapy alternated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: A single-arm phase II trial (CRC-PIPAC-II). Article Snippet: Background: Palliative systemic therapy alternated with electrostatic precipitation oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (ePIPAC) has never been prospectively investigated in patients with unresectable colorectal peritoneal metastases (CPM).. The CRC-PIPAC-II study aimed to assess safety, feasibility and efficacy of such bidirectional therapy.. Methods: This two-center, single-arm, phase II trial enrolled chemotherapy-naïve patients to undergo three treatment cycles, consisting of systemic therapy (CAPOX, FOLFOX, FOLFIRI, or FOLFOXIRI, all with bevacizumab) and oxaliplatin-based ePIPAC (92 mg/m2) with intravenous leucovorin (20 mg/m2) and 5-fluorouracil (400 mg/m2). Article Title: Enhanced intraperitoneal delivery of charged, aerosolized curcumin nanoparticles by electrostatic precipitation. Article Snippet: Therapeutic solutions were aerosolized at Article Title: Comparing patient reported abdominal pain between patients treated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC-OX) and primary colorectal cancer surgery. Article Snippet: Oxaliplatin was prepared in a total volume of 150 mL Article Title: Standardizing training for Pressurized Intraperitoneal Aerosol Chemotherapy. Article Snippet: Furthermore, important practical and safety aspects have been summarized comprehensively(1, 6- 8) Of note, access to the Article Title: Nab-PIPAC: a phase IB study protocol of intraperitoneal cisplatin and nab-paclitaxel administered by pressurised intraperitoneal aerosol chemotherapy (PIPAC) in the treatment of advanced malignancies confined to the peritoneal cavity Article Snippet: Cisplatin 10.5 mg/m2 body surface in 150 ml Article Title: Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Oxaliplatin, Cisplatin, and Doxorubicin in Patients with Peritoneal Carcinomatosis: An Open-Label, Single-Arm, Phase II Clinical Trial Article Snippet: A |